Smooth muscle tumors of soft tissue and non-uterine viscera: Biology and prognosis

Modern Pathology

Volumn 27, Issue SUPPL. 1, 2014, Pages

  Miettinen, Markku ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

bone and soft tissue; leiomyoma; leiomyosarcoma

Indexed keywords

DESMIN; ESTROGEN RECEPTOR; SMOOTH MUSCLE ACTIN; STEM CELL FACTOR RECEPTOR;

ABDOMINAL WALL; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALPORT SYNDROME; ANEUPLOIDY; ARTICLE; CANCER PROGNOSIS; CELL DEDIFFERENTIATION; COMPARATIVE GENOMIC HYBRIDIZATION; DIGESTIVE SYSTEM CANCER; DISTANT METASTASIS; EPSTEIN BARR VIRUS INFECTION; GASTROINTESTINAL STROMAL TUMOR; HAMARTOMA; HUMAN; KARYOTYPE; LEIOMYOMA; LEIOMYOMATOSIS; LEIOMYOSARCOMA; METASTASIS POTENTIAL; MITOSIS RATE; MIXED MULLERIAN TUMOR; MUSCLE TUMOR; NEEDLE BIOPSY; NERVE SHEATH TUMOR; PERIVASCULAR EPITHELIOID CELL TUMOR; POLYPLOIDY; PRIORITY JOURNAL; RETROPERITONEAL TUMOR; RETROPERITONEUM; SKIN TUMOR; SMOOTH MUSCLE FIBER; SOFT TISSUE TUMOR; TUMOR RECURRENCE; TUMOR SUPPRESSOR GENE; UTERUS MYOMA; VISCERA; ABDOMINAL TUMOR; BLADDER TUMOR; BRONCHUS TUMOR; DIFFERENTIAL DIAGNOSIS; ESOPHAGEAL LEIOMYOMA; HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER SYNDROME; MULLERIAN LEIOMYOMA; ORGAN TRANSPLANTATION; PILAR LEIOMYOMA; RETROPERITONEAL LEIOMYOSARCOMA; RETROPERITONEAL SARCOMA;

ANGIOMYOMA; CELL DIFFERENTIATION; HAMARTOMA; HERPESVIRUS 4, HUMAN; HUMANS; LEIOMYOMA; LEIOMYOSARCOMA; NEOPLASMS, MUSCLE TISSUE; PROGNOSIS; SOFT TISSUE NEOPLASMS; TERMINOLOGY AS TOPIC; TUMOR MARKERS, BIOLOGICAL;

EID: 84891689274     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2013.178     Document Type: Article

References (86)

1. Urbanek RW, Johnson WC. Smooth muscle hamartomas associated with Becker's nevus. Arch Dermatol 1978;114:104-106. (Pubitemid 8270047)
2. Berger TG, Levin MW. Congenital smooth muscle hamartoma. J Am Acad Dermatol 1984;11:709-712. (Pubitemid 14008801)
3. Slifman NR, Harrist TJ, Rhodes AR. Congenital arrector pili hamartoma. A case report and review of the spectrum of Becker's melanosis and pilar smoothmuscle hamartoma. Arch Dermatol 1985;121: 1034-1037. (Pubitemid 15014945)
4. Johnson MD, Jacobs AH. Congenital smooth muscle hamartoma. A report of six cases and review of the literature. Arch Dermatol 1989;125:820-822. (Pubitemid 19161130)
5. Zvulunov A, Rotem A, Merlob P, et al. Congenital smooth muscle hamartoma. Prevalence, clinical findings, and follow-up in 15 patients. Am J Dis Child 1990;144:782-784. (Pubitemid 20196674)
6. Gagne EJ, Su WP. Congenital smooth muscle hamartoma of the skin. Pediatr Dermatol 1993;10:142-145. (Pubitemid 23176141)
7. Grau-Massanes M, Raimer S, Colome-Grimmer M, et al. Congenital smooth muscle hamartoma presenting as a linear atrophic plaque: case report and review of the literature. Pediatr Dermatol 1996;13:222-225. (Pubitemid 26227009)
8. Jang HS, Kim MB, Oh CK, et al. Linear congenital smooth muscle hamartoma with follicular spotted appearance. Br J Dermatol 2000;142:138-142.
9. Gualandri L, Cambiaghi S, Ermacora E, et al. Multiple familial smooth muscle hamartomas. Pediatr Dermatol 2001;18:17-20. (Pubitemid 32163905)
10. Daroca PJ Jr, Reed RJ, Love GL, et al. Myoid hamartomas of the breast. Hum Pathol 1985;16: 212-219. (Pubitemid 15143666)
11. Fisher WC, Helwig EB. Leiomyomas of the skin. Arch Dermatol 1963;88:78-88.
12. Raj S, Calonje E, Kraus M, et al. Cutaneous pilar leiomyoma: clinicopathologic analysis of 53 lesions in 45 patients. Am J Dermatopathol 1997;19:2-9. (Pubitemid 27106726)
13. Kraft S, Fletcher CD. Atypical intradermal smooth muscle neoplasms: clinicopathologic analysis of 84 cases and reappraisal of cutaneous 'leiomyosarcoma'. Am J Surg Pathol 2011;35:599-607.
14. Kiuru M, Launonen V, Hietala M, et al. Familial cutaneous leiomyomatosis is a two-hit condition associated with renal cell cancer of characteristic histology. Am J Pathol 2001;159:825-829. (Pubitemid 32847173)
15. Alam NA, Rowan AJ, Wortham NC, et al. Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiency. Hum Mol Genet 2003;159:825-829.
16. Toro RJ, Nickerson ML,Wei MH, et al. Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America. Am J Hum Genet 2003;73:95-106. (Pubitemid 36793783)
17. Sifaki MK, Krueger-Krasagakis S, Kotsopuolos A, et al. Botulinum toxin type A-treatment of a patient with multiple cutaneous piloleiomyomas. Dermatology 2009;218:44-47.
18. Knoth W, Knoth-Born RC. Familial utero-cutaneous leiomyomatosis. Z Haut Geschlechtskr 1964;37: 191-206.
19. Sudarshan S, Linehan WM. Genetic basis of cancer of the kidney. Semin Oncol 2006;33:544-551. (Pubitemid 44511978)
20. Merino MJ, Torres-Cabala C, Pinto P, et al. The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome. Am J Surg Pathol 2007;31:1578-1585. (Pubitemid 47482473)
21. Hachisuga T, Hashimoto H, Enjoji M. Angioleiomyoma. A clinicopathologic reappraisal of 562 cases. Cancer 1984;54:126-130. (Pubitemid 14117058)
22. Granter SR, Badizadegan K, Fletcher CD. Myofibromatosis in adults, glomangiopericytoma, and myopericytoma: a spectrum of tumors showing perivascular myoid differentiation. Am J Surg Pathol 1998;22: 513-525. (Pubitemid 28213737)
23. Matsuyama A, Hisaoka M, Hashimoto H. Angioleiomyoma: a clinicopathologic and immunohistochemical reappraisal with special reference to the correlation with myopericytoma. Hum Pathol 2007;38: 645-651. (Pubitemid 46399891)
24. Beer TW. Cutaneous angiomyolipomas are HMB45 negative, not associated with tuberous sclerosis, and should be considered as angioleiomyomas with fat. Am J Dermatopathol 2005;27:418-421. (Pubitemid 41383296)
25. Fox SB, Heryet A, Khong TY. Angioleiomyomas: an immunohistochemical study. Histopathology 1990;16: 495-496.
26. Chan JKC, Frizzera G, Fletcher CDM, et al. Primary vascular tumors of lymph nodes other than Kaposi's sarcoma. Am J Surg Pathol 1992;16:335-350.
27. Laeng RH, Hotz MA, Borisch B. Angiomyomatous hamartoma of a cervical lymph node combined with hemangiomatosis and vascular transformation of sinuses. Histopathology 1996;29:80-84. (Pubitemid 26232529)
28. Billings SD, Al Folpe, Weiss SW. Do leiomyomas of deep soft tissue exist An analysis of highly differentiated smooth muscle tumors of deep soft tissue supporting two distinct subtypes. Am J Surg Pathol 2001;25:1134-1142. (Pubitemid 32777712)
29. Paal E, Miettinen M. Retroperitoneal leiomyomas. A clinicopathologic and immunohistochemical study of 56 cases with a comparison to retroperitoneal leiomyosarcomas. Am J Surg Pathol 2001;25:1355-1363. (Pubitemid 33022050)
30. Patil DT, Laskin WB, Fetsch JF, et al. Inguinal smooth muscle tumors in women-a dichotomous group consisting of Mullerian type leiomyomas and soft tissue leiomyosarcomas: an analysis of 55 cases. Am J Surg Pathol 2011;35:315-324.
31. Tavassoli FA, Norris HJ. Smooth muscle tumors of the vulva. Obstetr Gynecol 1979;53:213-217. (Pubitemid 9066928)
32. Nielsen GP, Rosenberg AE, Koerner FC, et al. Smoothmuscle tumors of the vulva. A clinicopathological study of 25 cases and review of the literature. Am J Surg Pathol 1996;20:779-793. (Pubitemid 26230741)
33. Bell SW, Kempson RL, Hendrickson MR. Problematic uterine smooth muscle neoplasms. Am J Surg Pathol 1994;18:535-558.
34. Tavassoli FA, Norris HJ. Peritoneal leiomyomatosis (Leiomyomatosis peritonealis disseminata): A clinicopathologic study of 20 cases with ultrastructural observations. Int J Gynecol Pathol 1982;1:59-74. (Pubitemid 13145740)
35. Bekkers RL, Willemsen WN, Shijf CP, et al. Leiomyomatosis peritonealis disseminata: does malignant transformation occur. A literature review. Gynecol Oncol 1999;75:158-163. (Pubitemid 29477822)
36. Bernstein SC, Roenigk RK. Leiomyosarcoma of the skin. Treatment of 34 cases. Dermatol Surg 1996;22: 631-635.
37. Kaddu S, Beham A, Cerroni L, et al. Cutaneous leiomyosarcoma. Am J Surg Pathol 1997;21:979-987. (Pubitemid 27407281)
38. Jensen ML, Jensen OM, Michalski W, et al. Intradermal and subcutaneous leiomyosarcoma: A clinicopathological and immunohistochemical study of 41 cases. J Cutan Pathol 1996;23:458-463. (Pubitemid 26364552)
39. Gustafson P, Willen H, Baldetrop B, et al. Soft tissue leiomyosarcoma. A population-based epidemiologic and prognostic study of 48 patients, including cellular DNA content. Cancer 1992;70:114-119.
40. Hashimoto H, Daimaru Y, Tsuneyoshi M, et al. Leiomyosarcoma of the external soft tissues. A clinicopathologic, immunohistochemical and electron microscopic study. Cancer 1986;57:2077-2088. (Pubitemid 16113789)
41. Farshid G, Pradham M, Goldblum J, et al. Leiomyosarcoma of somatic soft tissues. A tumor of vascular origin with multivariate analysis of outcome in 42 cases. Am J Surg Pathol 2002;26:14-24. (Pubitemid 34019988)
42. Svarvar K, Böhling T, Berlin Ö, et al. Clinical course of nonvisceral soft tissue leiomyosarcoma in 225 patients from the Scandinavian sarcoma group. Cancer 2007;109:282-291. (Pubitemid 46106243)
43. Varela-Duran J, Oliva H, Rosai J. Vascular leiomyosarcoma: the malignant counterpart of vascular leiomyoma. Cancer 1979;44:1684-1691. (Pubitemid 10140395)
44. Berlin O, Stener B, Kindblom LG, et al. Leiomyosarcoma of venous origin in the extremities. A correlated clinical, roentgenologic, and morphologic study with diagnostic and surgical implications. Cancer 1984;54: 2147-2159. (Pubitemid 15210798)
45. Venance SL, Burns KL, Veinot JP, et al. Contraction bands in visceral and vascular smooth muscle. Hum Pathol 1996;27:1035-1041. (Pubitemid 26347058)
46. Chen E, O'Connell F, Fletcher CD. Dedifferentiated leiomyosarcoma: clinicopathologic analysis of 18 cases. Histopathology 2011;59:1135-1143.
47. Watanabe K, Kusakabe T, Hoshi N, et al. H-caldesmon in leiomyosarcoma and tumors with smooth muscle cell differentiation: its specific expression in the smooth muscle tumor. Hum Pathol 1999;30:392-396. (Pubitemid 29177817)
48. Perez-Montiel MD, Plaza JA, Dominguez-Malagon H, et al. Differential expression of smooth muscle myosin, smooth muscle actin, H-caldesmon, and calponin in the diagnosis of myofibroblastic and smooth muscle lesions of skin and soft tissue. Am J Dermatopathol 2006;28:105-111. (Pubitemid 44270869)
49. Miettinen M. Immunoreactivity for cytokeratin and epithelial membrane antigen in leiomyosarcoma. Arch Pathol Lab Med 1988;112:637-640.
50. Iwata J, Fletcher CD. Immunohistochemical detection of cytokeratin and epithelial membrane antigen in leiomyosarcoma: a systematic study of 100 cases. Pathol Int 2000;50:7-14. (Pubitemid 30194087)
51. Sandberg AA. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: leiomyosarcoma. Cancer Genet Cytogenet 2005;161:1-19. (Pubitemid 41102169)
52. Stratton MR, Williams S, Fisher C, et al. Structural alterations of the RB1 gene in human soft tissue tumours. Br J Cancer 1989;60:202-205. (Pubitemid 19207837)
53. Kleinerman RA, Tucker MA, Abramson DH, et al. Risk of soft tissue sarcomas by individual subtype in survivors of hereditary retinoblastoma. J Natl Cancer Inst 2007;99:24-31.
54. Rajani B, Smith TA, Reith JD, et al. Retroperitoneal leiomyosarcomas unassociated with the gastrointestinal tract: a clinicopathologic analysis of 17 cases. Mod Pathol 1999;12:21-28. (Pubitemid 29059162)
55. Mingoli A, Cavallaro A, Sapienza P, et al. International registry of inferior vena cava leiomyosarcoma: analysis of a world series on 218 patients. Anticancer Res 1996;16:3201-3205. (Pubitemid 26390275)
56. Hines OJ, Nelson S, Quinones-Baldrich WJ, et al. Leiomyosarcoma of the inferior vena cava: prognosis and comparison with leiomyosarcoma of other anatomic sites. Cancer 1999;85:1077-1083. (Pubitemid 29115586)
57. Hollenbeck ST, Grobmyer SR, Kent KC, et al. Surgical treatment and outcomes in patients with primary inferior vena cava leiomyosarcoma. J Am Coll Surg 2003;197:575-579. (Pubitemid 38223842)
58. Ito H, Hornick JL, Bertagnolli MM. et al. Leiomyosarcoma of the inferior vena cava: Survival after aggressive management. Ann Surg Oncol 2007;14: 3534-3541. (Pubitemid 350160120)
59. Laskin WB, Fanburg-Smith JC, Burke AP, et al. Leiomyosarcoma of the inferior vena cava: clinicopathologic study of 40 cases. Am J Surg Pathol 2010; 34:873-881.
60. Seremetis MG, Lyons WS, de Guzman VC, et al. Leiomyomata of the esophagus. An analysis of 838 cases. Cancer 1976;38:2166-2177.
61. Miettinen Sarlomo-Rikala MSobin, Lasota J. Esophageal stromal tumors-a clinicopathologic, immunohistochemical and molecular genetic study of seventeen cases and comparison with esophageal leiomyomas and leiomyosarcomas. Am J Surg Pathol 2000;23: 121-132.
62. Hatch GF III, Wertheimer-Hatch L, Hatch KF, et al. Tumors of the esophagus. World J Surg 2000;24: 401-411. (Pubitemid 30158706)
63. Lonsdale RN, Roberts PF, Vaughan R, et al. Familial oesophageal leiomyomatosis and nephropathy. Histopathology 1993;20:127-133.
64. Ueki Y, Naito I, Oohashi T, et al. Topoisomerase I and II consensus sequences in a 17-kb deletion junction of the COL4A5 and COL4A6 genes and immunohistochemical analysis of esophageal leiomyomatosis associated with Alport syndrome. Am J Hum Genet 1998; 62:253-261. (Pubitemid 28110766)
65. Ueki Y, Naito I, Oohashi T, et al. Topoisomerase I and II consensus sequences in a 17-kb deletion junction of the COL4A5 and COL4A6 genes and immunohistochemical analysis of esophageal leiomyomatosis associated with Alport syndrome. Am J Hum Genet 1998;62:253-261. (Pubitemid 28110766)
66. Heidet L, Boye E, Cai Y, et al. Somatic deletion of the 5' ends of both the COL4A5 and COL4A6 genes in a sporadic leiomyoma of the esophagus. Am J Pathol 1998;152:673-678. (Pubitemid 28110713)
67. McKeeby JL, Li X, Vortmeyer AO, et al. Multiple leiomyomas of the esophagus, lung, and uterus in multiple endocrine neoplasia type 1. Am J Pathol 2001;159:1121-1127. (Pubitemid 32847203)
68. Miettinen M, Sarlomo-Rikala M, Sobin LH. Mesenchymal tumors of muscularis mucosae of colon and rectum are benign leiomyomas that should be separated from gastrointestinal stromal tumors-a clinicopathologic and immunohistochemical study of 88 cases. Mod Pathol 2001;14:950-956. (Pubitemid 32976781)
69. Miettinen M, Sarlomo-Rikala M, Sobin LH, et al. Gastrointestinal stromal tumors and leiomyosarcoma in the colon: a clinicopathologic, immunohistochemical, and molecular genetic study of 44 cases. Am J Surg Pathol 2000;24:1339-1352.
70. Miettinen M, Furlong M, Sarlomo-Rikala M, et al. Gastrointestinal stromal tumors, intramural leiomyomas, and and leiomyosarcomas in the rectum and anus: a clinicopathologic, immunohistochemical and molecular genetic study of 144 cases. Am J Surg Pathol 2001;25:1121-1133. (Pubitemid 32777711)
71. Miettinen M, Sobin LH, Lasota J. True smooth muscle tumors of the small intestine: a clinicopathologic, immunohistochemical, and molecular genetic study of 25 cases. Am J Surg Pathol 2009;33:430-436.
72. Park JS, Lee M, Kim HK, et al. Primary leiomyoma of the trachea, bronchus, and pulmonary parenchyma-a single-institutional experience. Eur J Cardiothorac Surg 2012;41:41-45.
73. Nuovo GJ, Schmittgen TD. Benign metastasizing leiomyoma of the lung: clinicopathologic, immunohistochemical, and micro-RNA analyses. Diagn Mol Pathol 2008;17:145-150.
74. Bowen JM, Cates JM, Kash S, et al. Genomic imbalances in benign metastasizing leiomyoma: characterization by conventional karyotypic, fluorescence in situ hybrid-ization, and whole genome SNP array analysis. Cancer Genet 2012;205:249-254.
75. Martin SA, Sears DL, Sebo TJ, et al. Smooth muscle neoplasms of the urinary bladder: a clinicopathologic comparison of leiomyoma and leiomyosarcoma. Am J Surg Pathol 2002;26:292-300. (Pubitemid 34184452)
76. McClain KL, Leach CT, Jenson HB, et al. Association of Epstein-Barr virus with leiomyosarcomas in children with AIDS. N Engl J Med 1995;332:12-18.
77. Purgina B, Rao UN, Miettinen M, et al. AIDSrelated EBV-associated smooth muscle tumors: A review of 64 published cases. Patholog Res Int 2011; 2011:561548.
78. Ross JS, Del Rosario A, Bui HX, et al. Primary hepatic leiomyosarcoma in a child with the acquired immunodeficiency syndrome. Hum Pathol 1992;23: 69-72.
79. Orlow SJ, Kamino H, Lawrence RL. Multiple subcutaneous leiomyosarcomas in an adolescent with AIDS. Am J Pediatr Hematol Oncol 1992;14:265-268.
80. van Hoeven KH, Factor SM, Kress Y, et al. Visceral myogenic tumors. A manifestation of HIV infection in children. Am J Surg Pathol 1993;17:1176-1181. (Pubitemid 23313792)
81. Litofsky NS, Pihan G, Corvi F, et al. Intracranial leiomyosarcoma: a neuro-oncological consequence of acquired immunodeficiency syndrome. J Neurooncol 1998;40:179-183. (Pubitemid 29010171)
82. Timmons CF, Dawson DB, Richards CS, et al. Epstein-Barr virus-associated leiomyosarcomas in liver transplantation recipients. Origin from either donor or recipient tissue. Cancer 1995;76:1481-1489.
83. Somers GR, Tesoriero AA, Hartland E, et al. Multiple leiomyosarcomas of both donor and recipient origin arising in heart-lung transplant patient. Am J Surg Pathol 1998;22:1423-1428. (Pubitemid 28499134)
84. Rogatsch H, Bonatti H, Menet A, et al. Epstein-Barr virus-associated multicentric leiomyosarcoma in an adult patient after heart transplantation: case report and review of the literature. Am J Surg Pathol 2000;24:614-621. (Pubitemid 30180757)
85. Deyrup AT, Lee VK, Hill CE, et al. Epstein-Barr virusassociated smooth muscle tumors are distinctive mesenchymal tumors reflecting multiple infection events. A clinicopathologic and molecular analysis of 29 tumors from 19 patients. Am J Surg Pathol 2006;30:75-82. (Pubitemid 43740212)
86. Lau PP, Wong OK, Lui PC, et al. Myopericytoma in patients with AIDS: a new class of Epstein-Barr virusassociated tumor. Am J Surg Pathol 2009;33: 1666-1672.